Skip to main content

Advertisement

Log in

HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The human leukocyte antigens (HLA) DRB1 polymorphism has been implicated in susceptibility to nasopharyngeal carcinoma (NPC). However, the results are inconsistent. The aim of this meta-analysis is to evaluate the association between the HLA-DRB1 polymorphisms and NPC risk. All eligible case–control studies published up to June 17, 2015 were identified by searching PubMed, Web of Science, CNKI, Wanfang, and Weipu databases. The NPC risk associated with the HLA-DRB1 polymorphism was estimated for each study by odds ratios (OR) together with its 95 % confidence interval (CI), respectively. Twelve studies with 1152 cases and 1600 controls were included. Overall, a significant positively association between the HLA-DRB1*03, *08, *09, and *10 alleles polymorphism and NPC risk were found (OR = 1.55, 95 % CI 1.30–1.86; OR = 1.44, 95 % CI 1.08–1.92; OR = 1.33, 95 % CI 1.06–1.67; OR = 1.82, 95 % CI 1.02–3.26, respectively), and the HLA-DRB1*01, *11, and *12 alleles were negatively associated with NPC risk (OR = 0.55, 95 % CI 0.39–0.78; OR = 0.62, 95 % CI 0.42–0.91; OR = 0.62, 95 % CI 0.47–0.81, respectively), but we failed to detect any association between other alleles and NPC risk. When stratified by ethnicity, similar results were observed among Asians for HLA-DRB1*03, *08, *09, *11, and *12 alleles and Tunisians for HLA-DRB1*01, *03, and *11 alleles; However, no significant association among Caucasians was observed. This meta-analysis suggests that the HLA-DRB1*03, *08, *09, and *10 alleles polymorphism contributed to the susceptibility of NPC, whereas HLA-DRB1*11 and *12 alleles polymorphism may be an important protective factor for NPC, especially of Asian populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

    Article  PubMed  Google Scholar 

  2. Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev 15:1765–1777

    Article  CAS  Google Scholar 

  3. Klein G (2002) Nasopharyngeal carcinoma (NPC) is an enigmatic tumor. Semin Cancer Biol 12:415–418

    Article  PubMed  Google Scholar 

  4. The MHC sequencing consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401:921–923

    Article  Google Scholar 

  5. Klein J, Sato A (2000) The HLA system. First of two parts. N Engl J Med 343:702–709

    Article  CAS  PubMed  Google Scholar 

  6. Klein J, Sato A (2000) The HLA system. Second of two parts. N Engl J Med 343:782–786

    Article  CAS  PubMed  Google Scholar 

  7. Burt RD, Vaughan TL, McKnight B et al (1996) Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomark Prev 5:879–887

    CAS  Google Scholar 

  8. Chen T, Wu R, Wang RZ (2013) A study on the correlation of HLA-DRBI and nasopharyngeal carcinoma among Han People in Xinjiang. J Xinjiang Med Univ 36:902–904

    CAS  Google Scholar 

  9. Hildesheim A, Apple RJ, Chen CJ et al (2002) Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94:1780–1789

    Article  CAS  PubMed  Google Scholar 

  10. Karanikiotis C, Daniilidis M, Karyotis N et al (2008) HLA class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma. Strahlenther Onkol 184:325–331

    Article  PubMed  Google Scholar 

  11. Li PK, Poon AS, Tsao SY, Ho S, Tam JS, So AK, Lai KN (1995) No association between HLA-DQ and -DR genotypes with nasopharyngeal carcinoma in southern Chinese. Cancer Genet Cytogenet 81:42–45

    Article  CAS  PubMed  Google Scholar 

  12. Lu L, Deng ZH, Gao SQ, Zou HY (2010) Study on the association between HLA alleles and nasopharyngeai carcinoma patients in Guangdong native population. Int J Blood Transfushematol 33:499–503

    Google Scholar 

  13. Makni H, Daoud J, Ben Salah H et al (2010) HLA association with nasopharyngeal carcinoma in southern Tunisia. Mol Biol Rep 37:2533–2539

    Article  CAS  PubMed  Google Scholar 

  14. Mokni-Baizig N, Ayed K, Ayed FB, Ayed S, Sassi F, Ladgham A, Bel Hadj O, El May A (2001) Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 61:55–58

    Article  CAS  PubMed  Google Scholar 

  15. Ooi EE, Ren EC, Chan SH (1997) Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer 74:229–232

    Article  CAS  PubMed  Google Scholar 

  16. Wang Z, Guo S, Yu P (2005) Correlative study on HLA-DR allelic polymorphisms and nasopharyngeal carcinoma in the Han nationality in Hunan province. Chin J Pathophysiol 21:1014–1015

    CAS  Google Scholar 

  17. Wang R, Hu Y, Yindom LM, Huang L, Wu R, Wang D, Chang C, Rostron T, Dong T, Wang X (2014) Association analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China. Hum Immunol 75:197–202

    Article  CAS  PubMed  Google Scholar 

  18. Zeng XH, Xiao LL, Li J, Lu JX, Wang XN (2007) Correlation of the polymorphism of HLA-A, B and DRB1 alleles with nasopharyngeal carcinoma in the south of China. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23:819–820

    CAS  PubMed  Google Scholar 

  19. Reinders J, Rozemuller EH, Otten HG, van der Veken LT, Slootweg PJ, Tilanus MG (2007) HLA and MICA associations with head and neck squamous cell carcinoma. Oral Oncol 43:232–240

    Article  CAS  PubMed  Google Scholar 

  20. Wang ZP, Guo SS, Yu P (2003) The correlation between HLA-DRB1 allelic polymorphisms and nasopharygeal carcinoma in Han people in Hunan Province. Pract Prev Med 10:129–131

    Google Scholar 

  21. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826

    Article  CAS  PubMed  Google Scholar 

  22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    CAS  PubMed  Google Scholar 

  24. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  CAS  PubMed  Google Scholar 

  25. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Cabrera T, Ruiz-Cabello F, Garrido F (1995) Biological implications of HLA-DR expression in tumours. Scand J Immunol 41:398–406

    Article  CAS  PubMed  Google Scholar 

  27. Sette A, Chesnut R, Fikes J (2001) HLA expression in cancer: implications for T cell-based immunotherapy. Immunogenetics 53:255–263

    Article  CAS  PubMed  Google Scholar 

  28. Yan L, Wang JM, Zeng K (2012) Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Br J Dermatol 167:768–777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shujuan Yang.

Ethics declarations

Conflict of interest

We declare that we have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yao, K., Yang, S., Shen, J. et al. HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis. Eur Arch Otorhinolaryngol 274, 297–303 (2017). https://doi.org/10.1007/s00405-016-4264-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4264-2

Keywords

Navigation